Boardroom Agenda
Allianz: Business Interruption Remains Huge Risk; Cyber Gaining Fast
Business interruption is the top concern of risk managers heading into 2016 for the fourth year in a row, but cyber is a fast-growing corporate worry, according to a new report from Allianz Global ...
Aspen Buys AgriLogic, Bringing More Changes to U.S. Crop Insurance
Aspen Insurance Holdings snatched up AgriLogic Insurance Services, a Kansas-based crop insurer and agriculture consultant, bring more changes to a sector that has already seen a spike in buying and ...
As the insurance market continues to stabilize, the next phase of the market will reward independent agencies that can respond...
China’s Anbang Insurance Plans More New York Investments
Anbang Insurance Group Co., the Chinese insurer whose almost $2 billion purchase of New York's Waldorf Astoria hotel set a U.S. industry record, isn't done investing in the financial capital. "New ...
Zurich’s Troubles Mount With Predictions of More General Insurance Losses
Zurich Insurance Group AG fell to the lowest in more than three years after Switzerland's biggest insurer put shareholders on notice that it expects a second straight quarterly loss in its general ...
What Investor Activism Means for Insurers—Those Under Attack and Those That Aren’t
Carl Icahn's demands for American International Group to split into three different companies may seem over the top to some. More importantly for the P/C market at large, however, is that the hedge ...
Executives On The Move at Everest Re, BHSI and Aspen Insurance
A retirement at Everest Re Group is spurring some executive leadership changes. Berkshire Hathaway Specialty Insurance Company expanded its team in Australia to handle the launch of new policies. ...
Icahn Ups Pressure on AIG CEO Hancock in Advance of ‘Vision’ Presentation
Activist investor Carl Icahn, who's pushing American International Group Inc. Chief Executive Officer Peter Hancock to shrink the insurer and boost returns, said the CEO's presentation next week on ...
Merck Will Pay $830M to Settle Securities Suit Over Recalled Heart Drug
U.S. drugmaker Merck & Co on Friday said it would pay $830 million to settle a federal class action lawsuit involving allegations the company failed to adequately inform investors about heart ...